Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review

Dulaglutide, a weekly injectable glucagon-like peptide-1 receptor agonist, has demonstrated effectiveness when combined with basal insulin. We examined whether the efficacy of dulaglutide is comparable to that of prandial insulin in kidney transplant (KT) recipients with type 2 diabetes mellitus (T2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hwi Seung, Lee, Jiwoo, Jung, Chang Hee, Park, Joong-Yeol, Lee, Woo Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640157/
https://www.ncbi.nlm.nih.gov/pubmed/33535737
http://dx.doi.org/10.4093/dmj.2020.0180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640157/
https://www.ncbi.nlm.nih.gov/pubmed/33535737
http://dx.doi.org/10.4093/dmj.2020.0180

Ejemplares similares